PINK:OTLC

Oncotelic Therapeutics Stock Insider Trading

etoro logo Buy OTLC
*Your capital is at risk
$0.0500
+0 (+0%)
At Close: Jun 03, 2026

Oncotelic Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 251.52M and sold 52.51K OTLC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 251.52M shares
Sell 52.51K shares
92% Buy Activity
Weak Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jul 08, 2021
Buy
Stock Options
A-Award
Shah Amit B.
Chief Financial Officer
C-Suite Officer 698 256
Value: $113.5K
Jul 08, 2021
Buy
Common Stock
A-Award
Shah Amit B.
Chief Financial Officer
C-Suite Officer 298 837
Value: $0
Jul 08, 2021
Buy
Stock Options
A-Award
Diamond David
Director
Director 451 467
Value: $73.4K
Jul 08, 2021
Buy
Common Stock
A-Award
Saund Saran
Chief Business Officer
Officer 102 519
Value: $0
Jul 08, 2021
Buy
Stock Options
A-Award
Saund Saran
Chief Business Officer
Officer 216 279
Value: $35.2K
Jul 08, 2021
Buy
Stock Options
A-Award
Saund Saran
Chief Business Officer
Officer 216 279
Value: $35.2K
Jul 08, 2021
Buy
Common Stock
A-Award
Saund Saran
Chief Business Officer
Officer 102 519
Value: $0
Jul 08, 2021
Buy
Stock Options
A-Award
Diamond David
Director
Director 451 467
Value: $73.4K
Jul 08, 2021
Buy
Common Stock
A-Award
Shah Amit B.
Chief Financial Officer
C-Suite Officer 298 837
Value: $0
Jul 08, 2021
Buy
Stock Options
A-Award
Shah Amit B.
Chief Financial Officer
C-Suite Officer 698 256
Value: $113.5K
Jul 08, 2021
Buy
Stock Options
A-Award
King Steven W
Director
Director 357 412
Value: $58.1K
Jul 08, 2021
Buy
Stock Options
A-Award
Trieu Vuong
Chairman And CEO
CEO / President 513 953
Value: $83.6K
Jul 08, 2021
Buy
Common Stock
A-Award
Trieu Vuong
Chairman And CEO
CEO / President 259 302
Value: $0
Jul 08, 2021
Buy
Stock Options
A-Award
Maida Anthony E Iii
Chief Clinical Officer
Officer 400 000
Value: $65.0K
Mar 31, 2021
Buy
Common Stock
C-Conversion
Maida Anthony E Iii
Chief Clinical Officer
Officer 938 646
Value: $0
Mar 31, 2021
Sell
Series A Convertible Preferred Stock
C-Conversion
Maida Anthony E Iii
Chief Clinical Officer
Officer 938
Value: $0
Mar 31, 2021
Buy
Common Stock
C-Conversion
Trieu Vuong
Chairman And CEO
CEO / President 74 455 719
Value: $0
Mar 31, 2021
Buy
Common Stock
C-Conversion
Trieu Vuong
Chairman And CEO
CEO / President 13 849 161
Value: $0
Mar 31, 2021
Buy
Common Stock
C-Conversion
Trieu Vuong
Chairman And CEO
CEO / President 5 672 025
Value: $0
Mar 31, 2021
Sell
Series A Convertible Preferred Stock
C-Conversion
Trieu Vuong
Chairman And CEO
CEO / President 5 672
Value: $0
Mar 31, 2021
Buy
Common Stock
C-Conversion
King Steven W
Director
Director 3 291 720
Value: $0
Mar 31, 2021
Sell
Series A Convertible Preferred Stock
C-Conversion
King Steven W
Director
Director 3 292
Value: $0
Mar 31, 2021
Buy
Common Stock
C-Conversion
Saund Saran
Chief Business Officer
Officer 16 354 961
Value: $0
Mar 31, 2021
Sell
Series A Convertible Preferred Stock
C-Conversion
Saund Saran
Chief Business Officer
Officer 16 355
Value: $0
Mar 31, 2021
Sell
Series A Convertible Preferred Stock
C-Conversion
Saund Saran
Chief Business Officer
Officer 16 355
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ONCOTELIC THERAPEUTICS, INC.
Oncotelic Therapeutics
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. It also develops O...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE